News Medical on MSN8d
New Study Sheds Light on How Bacteria ‘Vaccinate’ Themselves with Genetic Material from Dormant VirusesNow, Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage ...
Discover Magazine on MSN18d
CRISPR Eliminates Targeted Tumors by 50 PercentLearn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.
What’s really exciting about gene editing is precision and speed, says Pairwise cofounder and CEO Tom Adams, PhD.
Feb. 13, 2025 — A new study unravels the relationship between mitofusins (mitochondrial proteins) and autophagy. Using gene editing with CRISPR-Cas9, the team has been able to study these ...
Zacks Investment Research on MSN11d
CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...
CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...
AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback